Investors

Stock Info
OTCQBWIZP
News
Nov 12, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today reported topline results from its Phase IV clinical trial of its...

May 27, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that Bonus BioGroup (TASE: BONS.TA), a company in...

May 18, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that on May 13, 2020, Bonus BioGroup (TASE: BONS.TA),...

More News

SEC Filings
0001218683
Investor Presentation

Subscribe For Alerts
* Required Fields